Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series. - Wikidata - wikimedia - TriplyDB

Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series.

Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series.

http://www.wikidata.org/entity/Q45357942

about

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa.A Review of Antiviral Use for the Treatment of Chronic Hepatitis B Virus Infection in Pregnant Women.Vertical transmission of hepatitis B virus: challenges and solutions Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load.Safety of tenofovir during pregnancy for the mother and fetus: a systematic review.Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.Antiviral treatment among pregnant women with chronic hepatitis B.Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.Tenofovir rescue therapy in pregnant females with chronic hepatitis B Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial Chronic hepatitis B infection in pregnancy Management of chronic hepatitis B in patients from special populations Management of hepatitis B during pregnancy.Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya.Hepatitis B and C in pregnancy: a review and recommendations for care.Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus.Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysis.Therapeutic advances in the management of chronic hepatitis B infection.Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.Optimal management of HBV infection during pregnancy.Treatment of children with chronic viral hepatitis: what is available and what is in store.Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges.Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus.Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women.Overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories.Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.Quantifying perinatal transmission of Hepatitis B viral quasispecies by tag linkage deep sequencing.DNA polymerase inhibitors for treating hepatitis B: a safety evaluation.Prophylaxis of vertical HBV infection.Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus.Perinatal transmission in infants of mothers with chronic hepatitis B in California.Evaluation of hepatitis B virus transmission and antiviral therapy among hepatitis B surface antigen-positive pregnant women.Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region.Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk.A pregnant woman with acute hepatitis B in whom vertical transmission was prevented by tenofovir disoproxil fumarate.Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.

P2860

Q30391932-1DFABCB0-EC7D-45F3-91F4-1B05251056E8 Q33655929-CBC5BA7B-4DF5-487E-BA5B-A2606DEA03CE Q33711399-C215F8A1-39CB-4BA3-9695-BD0181E0C5F0 Q33774099-6B83AC5C-014A-46B5-8913-4E0D830BC7CF Q33829957-DFDEF987-DEC4-444D-B1F6-50DE70385EB0 Q34371989-105C06F4-B2F0-4CB1-8A1A-A4049E3EB438 Q34524575-3917F1F7-234C-4497-B6F0-1DADF622B376 Q34762578-744AD33B-66E3-45B8-AD06-DC8DF9886A78 Q34805931-D008C21C-342D-4F68-92A3-2FDB8764FA28 Q35128259-687E289C-5382-443D-8DF4-3B7D956B217A Q35184560-35227900-8F4F-45D5-8F1F-288B65B985EA Q35626775-CDC5F296-242C-48E1-8758-887BD3BF734A Q35664183-5536C5AA-812E-4593-B49C-BE991AD1C5B7 Q35838778-261A3CCC-0A83-45FD-B88E-7759AFD83937 Q36379986-7E14C5F4-322E-42C0-8588-85CDE4981C70 Q36448494-4E2E4C0D-11D8-41D5-A788-76468D04D5C6 Q36649138-4189E214-CDEF-4161-BED5-975E08BDC86C Q36738003-19991DA1-9AC2-43D3-8C5A-F97C80789429 Q36777589-970AF90D-79B9-4553-956C-795BFD35471B Q36971785-FE0655B5-32DE-4F1A-A121-098FD2DA2B54 Q37439967-63846A8E-B8F5-43A0-BC9D-BF319B77B8D2 Q38071406-D193D53D-F48E-418B-9E13-4B5D3D0EA676 Q38127616-AC7AF63E-5828-4D3B-82DC-262B2AC6F9F0 Q38174178-B96FF6A3-BFCD-428F-8E0A-D32657120746 Q38211738-E8D64867-16E1-4B04-9227-43F455075244 Q38212793-A95FAAF9-C852-49DC-9DB6-5F18AB22F97A Q38217668-FF60CEAC-B58D-499D-8ECF-979B95F9AA21 Q38240691-22DD8889-209F-402B-B620-15E2E251BC81 Q38293584-4A9DBBD3-2FA3-42B2-8785-C5F37CF18842 Q38599096-2D0C233C-8E2D-47A0-8630-86B71AD76A43 Q38692333-FFECEF35-E4FC-4C4E-9F35-F519BB99B385 Q38893286-7DD7FC75-0E71-4E2B-8A5A-5E41BFAEC6AD Q38966352-7985C4F3-7025-4EBF-8E57-C11881C864D4 Q39258357-5D8F872F-FBF8-40C8-A8B3-E58C09DAB6E3 Q40091528-397D72C5-7385-4673-B9F1-BA17EF7FEAD2 Q40540669-E3304CE4-C837-463D-ADA6-0052B3F7E5D0 Q40718152-758A8505-C8E2-407E-A736-14C4B633B997 Q40722693-62497F48-94B1-4B1A-9ADB-C6800CD5498D Q40729465-6AF4DEEE-49C3-4B2F-986E-71B572BB452D Q40934257-603F6598-CA6E-49C6-B8BF-AED06F15BC5C

P2860

Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series.

http://www.wikidata.org/entity/Q45357942

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Tenofovir disoproxil fumarate ...... pregnant women: a case series.

@en

Tenofovir disoproxil fumarate ...... pregnant women: a case series.

@nl

type

label

Tenofovir disoproxil fumarate ...... pregnant women: a case series.

@en

Tenofovir disoproxil fumarate ...... pregnant women: a case series.

@nl

prefLabel

Tenofovir disoproxil fumarate ...... pregnant women: a case series.

@en

Tenofovir disoproxil fumarate ...... pregnant women: a case series.

@nl

P1433

Q45357942-3556CB1A-084B-42A9-995A-70E7BE3FB791

P1476

Q45357942-53B16A34-07DF-4A08-BCA5-FA35F5353A17

P2093

Q45357942-03EF9BCE-2D44-45D6-851F-8F89F0395BE5

Q45357942-280D87D6-7171-4FB1-AC57-A5F396B6545B

Q45357942-81515E28-2A47-45C5-B5B8-19F8F29395EC

Q45357942-823E8DF2-D3FC-4C62-B027-B0E179C57FAB

Q45357942-E650689F-354D-4755-9969-6CFEA32B497E

Q45357942-E8384C71-137C-49F7-A0D4-820A0EFE8AED

P2860

Q45357942-00C5D518-5FBE-4BE4-B9E3-462DD9EE30EA

Q45357942-12A208D0-6920-48E1-9F29-321EA0532E6B

Q45357942-1307E489-8F12-4905-81C5-9D1079730144

Q45357942-1BC6030F-EFDC-4D86-94CD-01F5EC6C3D3B

Q45357942-1CC4F6BC-77C6-4CE8-A7C9-931A485A732F

Q45357942-2354D74F-75A8-4379-81A0-9E841129D3F7

Q45357942-4C6B62C5-FB64-4B3F-BCA2-5D70FFDE5B19

Q45357942-5344144D-C099-484E-B0B6-F3E2BA9CBA35

Q45357942-5A5D1CFF-8248-4E96-97EE-D2AEAF5B2313

Q45357942-5F34CEE8-6326-4A23-ADE3-DA0FD06E7D1E

P2888

Q45357942-DC170E35-AFED-4A34-8884-DBAA83128728

P304

Q45357942-1FE455ED-C50E-49D0-94DB-4BC6A21B92E7

P31

Q45357942-07C6195D-0284-4097-8F03-9E1BC15F6D0D

P356

Q45357942-ED1C5160-F39B-4A16-9565-B5FCA1217ED8

P433

Q45357942-3FAE904E-EE6F-42EA-8F85-F7040329F1E6

P478

Q45357942-44D8D7B6-7DD1-448F-B67D-7FA7222DDCE3

P50

Q45357942-3B393DB5-8CF2-447E-BB88-39E470CFE0C4

Q45357942-40E71DD4-96F6-464B-B318-B3E8A7116B38

P577

Q45357942-842CBC41-5667-4ED3-9749-C3AF993E863D

P6179

Q45357942-57E7B140-C82B-4D3A-85CD-BAFC047913B4

P698

Q45357942-1E174556-89F3-484B-88C0-B895100DDD41

P921

Q45357942-407B205B-E60C-4FC6-A2AD-49CA35FF4FA5

P356

S10620-012-2187-3

P1433

Digestive Diseases and Sciences

P1476

Tenofovir disoproxil fumarate ...... pregnant women: a case series.

@en

P2093

Calvin Q Pan

http://www.w3.org/2001/XMLSchema#string

Chalermrat Bunchorntavakul

http://www.w3.org/2001/XMLSchema#string

Gaurav Singhvi

http://www.w3.org/2001/XMLSchema#string

Li-Jun Mi

http://www.w3.org/2001/XMLSchema#string

Marc G Ghany

http://www.w3.org/2001/XMLSchema#string

William M Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic hepatitis B: update 2009

Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis.

Hepatitis B Therapy in Pregnancy

2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus.

Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?

A review of nucleoside reverse transcriptase inhibitor use to prevent perinatal transmission of HIV.

Natural history of chronic hepatitis B in Euro-Mediterranean and African countries.

P2888

s10620-012-2187-3

P304

2423-2429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-012-2187-3

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey Karsdon

K. Rajender Reddy

P577

2012-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033213045

http://www.w3.org/2001/XMLSchema#string

P698

22543886

http://www.w3.org/2001/XMLSchema#string

P921